Straits Times Index
3,292.70 +8.76 (+0.27%) Nikkei
27,772.93 +305.70 (+1.11%) Hang Seng
24,921.05 +793.20 (+3.29%) FTSE 100
7,589.66 +26.11 (+0.35%) BTC-USD
41,984.77 +614.87 (+1.49%) CMC Crypto 200
997.46 +2.71 (+0.27%)
Cue Health Inc. (HLTH)
After hours:
| Previous close | 9.15 |
| Open | 9.29 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 800 |
| Day's range | 8.72 - 9.60 |
| 52-week range | 8.53 - 22.55 |
| Volume | |
| Avg. volume | 775,388 |
| Market cap | 1.297B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.51 |
| Earnings date | 10 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.50 |
- Business Wire
Cue Health Reports Preliminary Fourth Quarter and Full Year 2021 Revenue
SAN DIEGO, January 11, 2022--Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, ("Cue’) today reported preliminary unaudited revenue for fourth quarter and full year 2021.
- Business Wire
Cue Health to Present at the 40th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, January 05, 2022--Cue Health ("Cue") (Nasdaq:HLTH), a healthcare technology company, announced today that its management team will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 5:15 p.m. Eastern Time.
- Motley Fool
Why Cue Health Blasted Higher Today
Monday was a very good day for stocks in general, but it was a standout day for healthcare diagnostics specialist Cue Health (NASDAQ: HLTH). On its website, Cue Health isn't shy to point out that it's the maker of the first molecular diagnostic test for COVID-19 approved by the U.S. Food and Drug Administration (FDA). Cue Health's COVID diagnostic test is also a product that can be administered at home with no training.
